Trial intelligence / Profile preview

PRO-148 vs Systane in mild-to-moderate dry eye syndrome

NCT01541891Phase 2Completed

Sponsor
Laboratorios Sophia
Start
Oct 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of PRO-148 in dry eye syndrome (DED), sponsored by Laboratorios Sophia. Started Oct 2011; status: completed.

02

Drugs

PRO-148
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01541891.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01541891.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call